ciprodex Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ciprodex, and what generic alternatives are available?
Ciprodex is a drug marketed by Sandoz and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.
This drug has nineteen patent family members in sixteen countries.
The generic ingredient in CIPRODEX is ciprofloxacin; dexamethasone. There are thirty-four drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the ciprofloxacin; dexamethasone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ciprodex
A generic version of ciprodex was approved as ciprofloxacin; dexamethasone by DR REDDYS on August 10th, 2020.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ciprodex?
- What are the global sales for ciprodex?
- What is Average Wholesale Price for ciprodex?
Summary for ciprodex
International Patents: | 19 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 3 |
Clinical Trials: | 10 |
Patent Applications: | 60 |
Drug Prices: | Drug price information for ciprodex |
Drug Sales Revenues: | Drug sales revenues for ciprodex |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ciprodex |
What excipients (inactive ingredients) are in ciprodex? | ciprodex excipients list |
DailyMed Link: | ciprodex at DailyMed |
Paragraph IV (Patent) Challenges for CIPRODEX
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
CIPRODEX | Otic Suspension | ciprofloxacin; dexamethasone | 0.3%/0.1% | 021537 | 1 | 2012-07-31 |
US Patents and Regulatory Information for ciprodex
ciprodex is protected by one US patents.
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sandoz | CIPRODEX | ciprofloxacin; dexamethasone | SUSPENSION/DROPS;OTIC | 021537-001 | Jul 18, 2003 | AB | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ciprodex
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sandoz | CIPRODEX | ciprofloxacin; dexamethasone | SUSPENSION/DROPS;OTIC | 021537-001 | Jul 18, 2003 | ⤷ Subscribe | ⤷ Subscribe |
Sandoz | CIPRODEX | ciprofloxacin; dexamethasone | SUSPENSION/DROPS;OTIC | 021537-001 | Jul 18, 2003 | ⤷ Subscribe | ⤷ Subscribe |
Sandoz | CIPRODEX | ciprofloxacin; dexamethasone | SUSPENSION/DROPS;OTIC | 021537-001 | Jul 18, 2003 | ⤷ Subscribe | ⤷ Subscribe |
Sandoz | CIPRODEX | ciprofloxacin; dexamethasone | SUSPENSION/DROPS;OTIC | 021537-001 | Jul 18, 2003 | ⤷ Subscribe | ⤷ Subscribe |
Sandoz | CIPRODEX | ciprofloxacin; dexamethasone | SUSPENSION/DROPS;OTIC | 021537-001 | Jul 18, 2003 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ciprodex
See the table below for patents covering ciprodex around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 1429780 | PROCEDE DE TRAITEMENT DE L'INFECTION DE L'OREILLE MOYENNE (METHOD OF TREATING MIDDLE EAR INFECTIONS) | ⤷ Subscribe |
Germany | 60006262 | ⤷ Subscribe | |
Japan | S63203629 | LOCALLY APPLICABLE BLEND OF DILASE INHIBITOR COMBINED WITH CORTICOSTEROIDS | ⤷ Subscribe |
Japan | 2003510263 | ⤷ Subscribe | |
China | 1376054 | ⤷ Subscribe | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ciprodex
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1429780 | 122012000070 | Germany | ⤷ Subscribe | PRODUCT NAME: KOMBINATION AUS CIPROFLOXACIN UND DEXAMETHASON, INSBESONDERE CIPROFLOXACINHYDROCHLORID UND DEXAMETHASON; NAT. REGISTRATION NO/DATE: 85150.00. 00 20120830; FIRST REGISTRATION: DAENEMARK 48976 20120808 |
1429780 | 132013902137451 | Italy | ⤷ Subscribe | PRODUCT NAME: CIPROFLOXACINA E DESAMETASONE(CILODEX); AUTHORISATION NUMBER(S) AND DATE(S): 48976, 20120810;041182015/M, 20121106 |
1429780 | CA 2012 00045 | Denmark | ⤷ Subscribe | |
1429780 | SPC/GB12/058 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003 |
1429780 | 13C0012 | France | ⤷ Subscribe | PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Ciprodex Market Analysis and Financial Projection Experimental
More… ↓